GOLM1 modulates EGFR/RTK cell-surface recycling to drive hepatocellular carcinoma metastasis

Cited by (236)

Items 101–200 of 236

1. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis
   Bin Wang, Xing Sun, Kejian Huang, Li-Sheng Zhou, Zhengjun Qiu · 2021 · World Journal of Gastroenterology
2. Research progress on GP73 in malignant tumors
   Rong Liang, Ziyu Liu, Xuemin Piao, Mingtang Zuo, Jinyan Zhang, Zhihui Liu, Yongqiang Li, Yan Lin · 2018 · OncoTargets and Therapy
3. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway
   Xiang Ding, Gang Deng, Junhui Liu, Baohui Liu, Fanen Yuan, Xue Yang, Qianxue Chen · 2019 · Brain Research
4. Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish
   Juanjuan Luo, Pei Liu, Chunjiao Lu, Wan-Ping Bian, Dongsheng Su, Chenchen Zhu, Shaolin Xie, Yihang Pan, Ningning Li, Wei Cui et al. · 2020 · Brain
5. STAT3 activates the transcription of lncRNA NR2F1‐AS1 to promote the progression of melanoma via regulating the miR‐493‐5p/GOLM1 axis
   Mei Bai, Zongzhou Wu, Yanli Huang, Jin Ke, Qing Xu, Xiong Wang · 2021 · The Journal of Gene Medicine
6. Deciphering a profiling based on multiple post-translational modifications functionally associated regulatory patterns and therapeutic opportunities in human hepatocellular carcinoma
   Yuanxiang Lao, Yirong Jin, Songfeng Wu, Ting Fang, Qiang Wang, Longqin Sun, Beicheng Sun · 2024 · Molecular Cancer
7. Supervillin promotes tumor angiogenesis in liver cancer
   Chenggang Zhao, Zhiyang Zhao, Zhen Wang, Lizhu Hu, Hongzhi Wang, Zhiyou Fang · 2020 · Oncology Reports
8. Recent advances of GOLM1 in hepatocellular carcinoma
   Jiuliang Yan, Binghai Zhou, Hui Li, Lei Guo, Qing‐Hai Ye · 2020 · Hepatic Oncology
9. Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma
   Xiaolu Ma, Keyu Zhu, Yueda Chen, Weiguo Tang, Suhong Xie, Hui Zheng, Ying Tong, Yanchun Wang, Ning Ren, Lin Guo et al. · 2022 · Oncogene
10. PELI1 and EGFR cooperate to promote breast cancer metastasis
    Jie Qi, Guangsen Xu, Xiaoxia Wu, Chunhua Lu, Yuemao Shen, Baobing Zhao · 2023 · Oncogenesis
11. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma
    Rongchang Wang, Zheng Yu, Fan Chen, Chunlian Liao, Qian Wang, Xiaohui Huang · 2017 · Human Pathology
12. Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
    Qianhui Xu, Yuanbo Hu, Shaohuai Chen, Yulun Zhu, Siwei Li, Feng Shen, Yifan Guo, Tao Sun, Xiaoyu Chen, Jinpeng Jiang et al. · 2021 · Frontiers in Molecular Biosciences
13. GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways
    Xiaoli Yang, Congwen Wei, Ning Liu, Feixiang Wu, Jian‐Kang Chen, Cui Wang, Zhen-Yu Jim Sun, Yufei Wang, Liping Liu, Xiaoli Zhang et al. · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
14. Suppression of GOLM1 by EGCG through HGF/HGFR/AKT/GSK-3β/β-catenin/c-Myc signaling pathway inhibits cell migration of MDA-MB-231
    Ling Xie, Jun Yi, Yong-Jia Song, Mengyao Zhao, Liqiang Fan, Liming Zhao · 2021 · Food and Chemical Toxicology
15. Vesicle transporter GOLT1B mediates the cell membrane localization of DVL2 and PD-L2 and promotes colorectal cancer metastasis
    Tengfei Liu, Binbin Liu, Yiting Liu, Xingzhi Feng, Xuefei Jiang, Jiahui Long, Qianling Gao, Zihuan Yang · 2021 · Cancer Cell International
16. Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma
    Zhenshan Zhang, Leilei Wu, Juan Li, Jiayan Chen, Yu Qi, Hui Yao, Yaping Xu, Liang Liu · 2022 · Journal of Translational Medicine
17. Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma
    Xinyang Hu, Shijin Yuan, Sining Zhou, Ting Sun, Chaoqun Wang, Shilong Ying, Heping Zhu, Jingfeng Luo, Hongchuan Jin, Yiming Liu · 2023 · International Journal of Biological Sciences
18. Association between blood lipid levels and the risk of liver cancer: a systematic review and meta-analysis
    Zhihui Zhang, Shicong Xu, Meixuan Song, Weirong Huang, Manlin Yan, Xianrong Li · 2024 · Cancer Causes & Control
19. Coordinated ASBT and EGFR Mechanisms for Optimized Liraglutide Nanoformulation Absorption in the GI Tract
    Seho Kweon, Seong Jin Park, Ha Kyeong Lee, Seo Hee Kang, Kwan-Young Chang, Jeong Uk Choi, Jooho Park, Jung‐Hyun Shim, Jin Woo Park, Youngro Byun · 2024 · International Journal of Nanomedicine
20. Golgi apparatus targeted therapy in cancer: Are we there yet?
    Zheng Yang Lee, Wen Hwei Lee, Jing Sheng Lim, Afiqah Ali Ajmel Ali, Jason Siau Ee Loo, Agustono Wibowo, Mohd Fazli Mohammat, Jhi Biau Foo · 2024 · Life Sciences
21. GOLM1-regulated EGFR/RTK recycling is a novel target for combating HCC metastasis
    Wenwei Zhu, Lun–Xiu Qin · 2016 · Science China Life Sciences
22. Research progress on the role of cholesterol in hepatocellular carcinoma
    Peng Li, Qi Yan, Zhaolin Chen, Ying Hu, Yuansong Sun, Miao Yu, Yincui Wu, Yan Yao, Liangsong Tao, Fei Chen et al. · 2022 · European Journal of Pharmacology
23. Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
    Sun, Liang, Liu, Zitao, Wu, Zhengyi, Ning, Ke, Hu, Junwen, Chen, Zhendong, Wu, Zhipeng, Yin, Xiangbao · 2023 · Frontiers in Immunology
24. Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research
    Jerry D. Monroe, Faiza Basheer, Yann Gibert · 2021 · Cells
25. RAB22A sorts epithelial growth factor receptor (EGFR) from early endosomes to recycling endosomes for microvesicles release
    Yujie Lin, Denghui Wei, Xiaobo He, Lanqing Huo, Jingxuan Wang, Xia Zhang, Yuanzhong Wu, Ruhua Zhang, Ying Gao, Tiebang Kang · 2024 · Journal of Extracellular Vesicles
26. GOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth
    Meghana Nagaraj, Marcus Höring, Maria A. Ahonen, Van Dien Nguyen, You Zhou, Helena Vihinen, Eija Jokitalo, Gerhard Liebisch, P.A. Nidhina Haridas, Vesa M. Olkkonen · 2022 · Journal of Lipid Research
27. AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models
    Kai Yu Ng, Tin-Yan Koo, Ianto Bosheng Huang, Terence K. Lee, Tsz-Lok Fong, Ya Gao, Tin Lok Wong, Yuan Gao, Jing‐Ping Yun, Xin‐Yuan Guan et al. · 2025 · Science Translational Medicine
28. The critical role of B4GALT4 in promoting microtubule spindle assembly in HCC through the regulation of PLK1 and RHAMM expression
    Zhe Dai, Kun Wang, Yin Han Gao · 2021 · Journal of Cellular Physiology
29. Blockade of PD ‐1 and CTLA ‐4: A potent immunotherapeutic approach for hepatocellular carcinoma
    Kai Hou, Xiaohui Xu, Xin Ge, Jiacen Jiang, Fan Ouyang · 2023 · BioFactors
30. GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers
    Yitong Li, Weiqing Shao, Zhenmei Chen, Xiaochen Ma, Chenhe Yi, Baorui Tao, Bo Zhang, Yue Ma, Guo Zhang, Rui Zhang et al. · 2024 · Clinical and Molecular Hepatology
31. Identification of potential diagnostic and prognostic biomarkers for prostate cancer
    Qiang Zhang, Xiujuan Yin, Zhiwei Pan, Yingying Cao, Shaojie Han, Guojun Gao, Zhiqin Gao, Zhifang Pan, Weiguo Feng · 2019 · Oncology Letters
32. Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning
    Xiaoming Li, Lin Cheng, Chuanming Li, Xianling Hu, Xiaofei Hu, Liang Tan, Qing Li, Chen Liu, Jian Wang · 2021 · Journal of Clinical and Translational Hepatology
33. Golgi Phosphoprotein 2 Is a Novel Regulator of IL-12 Production and Macrophage Polarization
    Wei Zhang, Ha-Jeong Kim, Jiyang Lv, Na Zhao, Xiaojing Ma · 2018 · The Journal of Immunology
34. Trafficking of Adhesion and Growth Factor Receptors and Their Effector Kinases
    Christina Schoenherr, Margaret C. Frame, Adam Byron · 2018 · Annual Review of Cell and Developmental Biology
35. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage
    Dong Wang, Zhiming Wang, Sai Zhang, Haijun Wu, Yiming Tao · 2018 · Cellular Physiology and Biochemistry
36. A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients
    Jian Zhang, Manka Zhang, Huimin Ma, Xincheng Song, Lingling He, Xiaohui Ye, Xin Li · 2019 · Archives of Medical Science
37. Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
    Yuzhao Wang, Zibin Chen, Weikai Wang, Lijuan Jiang, Xiaoyu Liang, Zhuowei Liu, Zikun Ma · 2026 · Cancer Cell
38. GOLM1 Promotes Pulmonary Fibrosis through Upregulation of NEAT1
    Yani Wang, Danjing Hu, Lin‐Yan Wan, Shuhui Yang, Song Liu, Zixi Wang, Jie Li, Jia Li, Zhoude Zheng, Chongsheng Cheng et al. · 2023 · American Journal of Respiratory Cell and Molecular Biology
39. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer
    Xuke Qin, Lin Liu, Yanze Li, Hongbo Luo, Hui Chen, Xiaodong Weng · 2023 · Technology in Cancer Research & Treatment
40. The GOLM1-ACLY pathway regulates macrophage-secreted EFEMP1 via H3K27ac modifications to drive tumor progression
    Lan Zhen, Min Min, Xinglin Mo, Guilin Zhao, Huilong Li, Muyi Liu, Luming Wan, Xiaopan Yang, Linfei Huang, Yanhong Zhang et al. · 2025 · Journal of Advanced Research
41. Exosomes Derived from microRNA-27a-3p Overexpressing Mesenchymal Stem Cells Inhibit the Progression of Liver Cancer through Suppression of Golgi Membrane Protein 1
    Christian Cedric Bongolo, Erick Thokerunga, Qian Yan, Mohamed Bassirou Moukeila Yacouba, Chao Wang · 2022 · Stem Cells International
42. DDX3 suppresses hepatocellular carcinoma progression through modulating the secretion and composition of exosome.
    Yi-Yuan Su, Chi-Hong Chao, Hsiang-Yu Hsu, Hao-Kang Li, Yiling Wang, Yan‐Hwa Wu Lee, Ru-Tsun Mai · 2023 · PubMed Central
43. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR
    Jaidev Bapat, Tomomi M. Yamamoto, Elizabeth R. Woodruff, Lubna Qamar, Railey G. Mikeska, Katherine M. Aird, Zachary L. Watson, Lindsay W. Brubaker, Benjamin Guy Bitler · 2023 · Cancer Gene Therapy
44. TMED2 promotes glioma tumorigenesis by being involved in EGFR recycling transport
    Changning Sun, Yihan Zhang, Zhuangzhi Wang, Jin Chen, Junhua Zhang, Yuchao Gu · 2024 · International Journal of Biological Macromolecules
45. GP73 blockade alleviates abnormal glucose homeostasis in diabetic mice
    Xiaopan Yang, Xiaojing Fan, Jiangyue Feng, Tinghui Fan, Jingfei Li, Linfei Huang, Luming Wan, Huan Yang, Huilong Li, Jing Gong et al. · 2022 · Journal of Molecular Endocrinology
46. EPS8L3 promotes hepatocellular carcinoma proliferation and metastasis by modulating EGFR dimerization and internalization.
    Zefeng Xuan, Long Zhao, Zequn Li, Wenfeng Song, Jun Chen, Jian Chen, Hao Chen, Guangyuan Song, Cheng Jin, Mengqiao Zhou et al. · 2020 · PubMed Central
47. GOLM1 facilitates human colorectal cancer progression and metastasis via activating the AKT/GSK3β/EMT axis
    Zonglei Mao, Yong Gui Wu, Pingan Yao, Chungen Xing · 2023 · Neoplasma
48. A Systems Approach to Interrogate Gene Expression Patterns in African American Men Presenting with Clinically Localized Prostate Cancer
    Gary Hardiman, Stephen J. Savage, E. Starr Hazard, Willian A. da Silveira, Rebecca Anne Morgan, Adam Harris, Melanie S. Jefferson, Robert C. Wilson, Susan Caulder, Linda Ambrose et al. · 2021 · Cancers
49. ACOT12-mediated acetyl-CoA hydrolysis suppresses intrahepatic cholangiocarcinoma metastasis by inhibiting epithelial-mesenchymal transition
    Xu Hui Zhou, Yujie Zhou, Weiqing Shao, Hong Liang, Ming‐De Lu, Wenwei Zhu · 2022 · Journal of Cancer
50. Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability
    Zhenguo Zi, Shujuan Du, Liming Zhang, Yuebo Wang, Ling Ding, Chongqi Zhang, Huanyu Wang, Jan M. Pawlicki, Yuan Cai, Yazhou Yao et al. · 2023 · Blood Advances
51. GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma
    Peiyi Xie, Mengyuan Wu, Hui Wang, Bo Zhang, Zihao Zhang, Jiuliang Yan, Mincheng Yu, Qiang Yu, Yufei Zhao, Da Huang et al. · 2024 · Oncogene
52. PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
    Fuqiang Huang, Jing Guo, Na Zhao, Mengjie Hou, Xiaochen Gai, Shuhui Yang, Pei Cai, Yanan Wang, Qian Ma, Qi Zhao et al. · 2024 · Journal of Translational Medicine
53. Golgi Phosphoprotein 3 Confers Radioresistance via Stabilizing EGFR in Lung Adenocarcinoma
    Guodong Chen, Peizhong Kong, Miaomiao Yang, Wanglai Hu, Kevin M. Prise, K.N. Yu, Shujun Cui, Feng Qin, Gang Meng, Waleed Abdelbagi Almahi et al. · 2021 · International Journal of Radiation Oncology*Biology*Physics
54. Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment
    Pingping Feng, Xinyang Hu, Sining Zhou, Xianyong Liu, Linghui Zeng, Yiming Liu · 2025 · Frontiers in Immunology
55. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo‐sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation
    Mei Zhao, Xuelian Li, Xin Chen · 2021 · Journal of Bioenergetics and Biomembranes
56. Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma
    De-Zhen Guo, Ao Huang, Yu-Peng Wang, Ya Cao, Jia Fan, Xin-Rong Yang, Jian Zhou · 2021 · Journal of Clinical and Translational Hepatology
57. Unveiling the impact of GOLM1 / GP73 on cytokine production in cancer and infectious disease
    Myrthe T. Frans, Ella M Kuipers, Frans Bianchi, Geert van den Bogaart · 2023 · Immunology and Cell Biology
58. Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX)
    Heike Liewen, Norbert Markuly, Heinz Philipp Laubli, Yang Liu, Matthias Sebastian Matter, Nora Liewen, Christoph Renner, Alfred Zippelius, Frank Stenner · 2019 · Targeted Oncology
59. Genetic insight into putative causes of xanthelasma palpebrarum: a Mendelian randomization study
    Wenting Hu, Yaozhong Liu, Lian Cuihong, Haocheng Lu · 2024 · Frontiers in Immunology
60. PRKDC regulates cGAMP to enhance immune response in lung cancer treatment
    Zhanghao Huang, Runqi Huang, Jun Zhu, Youlang Zhou, Jiahai Shi · 2024 · Frontiers in Immunology
61. RETRACTED: Identification of GOLM1 as a positively regulator of tumor metastasis by regulating MMP13 in gastric carcinoma
    Xian Min Li, Li Li Cao · 2019 · Cancer Biomarkers · Retracted
62. Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF
    Jingjing Tong, Mingjie Yao, Xiuying Mu, Leijie Wang, Xiajie Wen, Xingran Zhai, Xiang Xu, Yu Wang, Jing Chen, Xiangwei Zhai et al. · 2022 · Journal of Clinical and Translational Hepatology
63. A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
    Weiming Yu, Guowei Li, Ming-Geng Lou, Zhengyu Wu · 2023 · BMC Gastroenterology
64. Genomic Amplification of TBC1D31 Promotes Hepatocellular Carcinoma Through Reducing the Rab22A‐Mediated Endolysosomal Trafficking and Degradation of EGFR
    Pengbo Cao, Hongxia Chen, Ying Zhang, Qi Zhang, Mengting Shi, Huihui Han, Xiaowen Wang, Liang Jin, Bingqian Guo, Rongjiao Hao et al. · 2024 · Advanced Science
65. GCC2 promotes non-small cell lung cancer progression by maintaining Golgi apparatus integrity and stimulating EGFR signaling pathways
    Min-Sang Kim, Hyesun Jeong, Byeong Hyeon Choi, Ji‐Ho Park, Gun Seop Shin, Jik‐Han Jung, Hyunku Shin, Ka‐Won Kang, Ok Hwa Jeon, Jewon Yu et al. · 2024 · Scientific Reports
66. RNASET2 Deficiency Induces Hepatocellular Carcinoma Metastasis through Cholesterol‐Triggered MET Activation
    Yanquan Xu, Yu Chen, Jiangang Zhang, Jingchun Wang, Shuai Yang, Huakan Zhao, Lei Wu, Juan Lei, Yu Zhou, Jin Peng et al. · 2025 · Advanced Science
67. MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling
    Dongxiao Ding, Yunqiang Zhang, Xuede Zhang, Ke Shi, Wenjun Shang, Junjie Ying, Li Wang, Zhongjie Chen, Haihua Hong · 2022 · Molecular Biotechnology
68. LncRNA ASB16-AS1 accelerates cellular process and chemoresistance of ovarian cancer cells by regulating GOLM1 expression via targeting miR-3918
    Yang Fan, Long Wang, Xuechuang Han, Hongyun Ma, Na Zhang, Lina She · 2023 · Biochemical and Biophysical Research Communications
69. Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma
    Yan Lin, Ziqin He, Xing Gao, Lu Lu, Cheng Chang Lu, Julu Huang, Min Luo, Jiazhou Ye, Rong Liang · 2022 · Oxidative Medicine and Cellular Longevity
70. The link between the trans-Golgi network and tumour progression
    Leila Jahangiri · 2025 · Molecular Biology Reports
71. Powering Tumor Metastasis with Recycled Fuel
    Mien‐Chie Hung, Ri‐Yao Yang, Yutong Sun · 2016 · Cancer Cell
72. Knockdown Rab11‐FIP2 inhibits migration and invasion of nasopharyngeal carcinoma via suppressing Rho GTPase signaling
    Guofei Feng, Li-Ting Qin, Zhipeng Liao, Xiling Xiao, Bo Li, Wanmeng Cui, Libin Liang, Yingxi Mo, Guangwu Huang, Ping Li et al. · 2019 · Journal of Cellular Biochemistry
73. Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
    Sven Heiko Loosen, J Halpap, Simon Labuhn, Jan Bednarsch, Patrick H. Alizai, Anjali A. Roeth, Sven Arke Lang, Mihael Vucur, Jakob Nikolas Kather, Wolfram Trudo Knoefel et al. · 2022 · Cancers
74. Regulation on tumor metastasis by Raf kinase inhibitory protein
    Chi‐Tan Hu, Jayaprakash Mandal, Wen‐Sheng Wu · 2021 · Tzu Chi Medical Journal
75. New use of an old drug: mechanism of oseltamivir phosphate inhibiting liver cancer through regulation of lipophagy via NEU1
    Yuyu Chen, Peiyu Han, Haixia Zhu, Wenchao Zhang, Xiaoyu Ma, Yiting He, Hetian Chen, Weiwei He, Yu Wu, Yuqiu Ge · 2025 · Frontiers in Pharmacology
76. GTPase GPN3 facilitates cell proliferation and migration in non-small cell lung cancer by impeding clathrin-mediated endocytosis of EGFR
    Linlin Xu, Jiankun Guo, Xinsheng Xie, Hailong Wang, Alan Jiang, Changhua Huang, Hua Yang, Shiwen Luo, Limin Chen · 2025 · Cell Death Discovery
77. Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma
    Ran Wei, Ou Qi Feng, Yao Ze Hui, Xiaohui Huang, Ping Li · 2023 · Bioscience Reports
78. Quinidine dosage in children using population estimates.
    G J Burckart, José Marı́n-Garcı́a · 1986 · PubMed
79. GOLM1 as a Potential Therapeutic Target Modulates B7-H3 Secretion to Drive Ovarian Cancer Metastasis
    Junhua Guan, Yun-Peng Qin, Guiyuan Deng, Haihong Zhao · 2022 · Evidence-based Complementary and Alternative Medicine
80. Inhibition of AMPKα Pathway by Podocyte GOLM1 Exacerbates Diabetic Nephrology in Mice
    Peng Hui Xu, Kaiqiang Li, Huasong Liu, Aibo Xu, Zhe-Wei Zhang, Yimin Yang, Xiaobo Lai, Ke Hao, Kui Fang, Zeyu Lai et al. · 2025 · Advanced Science
81. Harnessing miR-145 in NSCLC: mechanistic roles, diagnostic-prognostic utility, and therapeutic potential
    Safa Tahmasebi, Davar Amani, Ian Michael Adcock, Esmaeil Mortaz · 2025 · Cancer Cell International
82. The first structure of human Golm1 coiled coil domain reveals an unexpected tetramer and highlights its structural diversity
    Wenfeng Bai, Bowen Li, Pei Jung Wu, Xinzhu Li, Xiaochen Huang, Ning Shi, Congcong Yang, Fen Hu, Xi Xie · 2024 · International Journal of Biological Macromolecules
83. GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR ‐driven transcriptional activation
    Guang Yan, Tianhang Zhu, Jiawei Zhou, Xia Li, Zonghua Wen, Miuhuitijiang Bahaerguli, Zhiyong Zhang, Yuejun Du, Cheng-Yao Li, Xiaojun Shi et al. · 2024 · Journal of Cellular and Molecular Medicine
84. GP73: the key to unlocking immunotherapies efficacy in solid tumors?
    Rebecca J. Bayliss, Alan L. Parker · 2025 · Journal for ImmunoTherapy of Cancer
85. Association of GOLPH2 gene polymorphisms (rs10868366 and rs7019241) with the risk of Alzheimer's disease: Evidence from a meta-analysis
    Md Abdul Barek, Md. Abdul Aziz, Sarah Jafrin, Mohammad Safiqul Islam · 2021 · Meta Gene
86. One Novel BiP/GRP78 Inhibitor YUM70 Induces GSDME Dependent Pyroptosis and Enhances Sensitivity To EGFR Inhibitors in cholangiocarcinoma and hepatocellular carcinoma
    Lei Sun, Yanan Liu, Hao Zhou, Mingyan Zhang, Xuelei Cao, Jian Zhang · 2022 · Research Square
87. Construction and validation of golgi apparatus-related genes as predictors of the immune microenvironment and prognosis in colorectal cancer
    Chen, Jie, Wang, Feng · 2026 · Translational Oncology
88. Insight into the function of the Golgi membrane protein GOLM1 in cholangiocytes through interactomic analysis
    Meghana Nagaraj, Sharath Kumar Goud Emmagouni, Vaishali Chaurasiya, Luyang Li, Van Dien Nguyen, Salla Keskitalo, Markku T Varjosalo, You Zhou, P.A. Nidhina Haridas, Vesa M. Olkkonen · 2025 · FEBS Letters
89. GP73 inhibition alleviates hepatic fibrosis by suppressing TGF-β/mTOR signaling pathways
    Yue Guo, Meng‐Yuan Liu, Yun-Qi Mo, Lin‐Yan Wan, Ya-Nan Wang, Shengyong Wang, Yi‐Ran Ni, Zhiying Li, Ying Wang, Xiao-Lian Wang et al. · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
90. Meeting report: Metastasis Research Society–Chinese Tumor Metastasis Society joint conference on metastasis
    Katherine T. Venmar, Lucia Borriello, Thomas R. Cox, Conor C. Lynch, Andries Zijlstra, Barbara Fingleton, Miodrag Gužvić, Robin L. Anderson, Josh Neman · 2017 · Clinical & Experimental Metastasis
91. Multiple Omics Data Integration
    Guangrong Qin, Zhenhao Liu, Lu Xie · 2019 · Elsevier eBooks
92. The expression of VEGF and cyclin D1/EGFR in common primary liver carcinomas in Egypt: an immunohistochemical study
    Dina Sweed, Shaymaa El Gammal, Shimaa Kilany, Shimaa Abdelsattar, Sara Mohamed Abd Elhamed · 2023 · ecancermedicalscience
93. ANKRD17 induces pro-survival signaling pathways that enhance cellular invasion and migration during hepatocellular carcinoma tumorigenesis
    Vincent W. Keng, Shan Su, Elyse S T Chui, Jeffrey C. To, Yaojun Zhang, Xiaoxiao Li · 2025 · iScience
94. [Effects of arsenic trioxide on migration, invasion and apoptosis of hepatocellular carcinoma HepG2 cells].
    Jia He, Bowen Xu, Wenbo Gao, Guanyue Su, Hongchi Yu, Yang Shen, Xiaoheng Liu · 2020 · PubMed Central
95. Targeting of EGFR Induced Signaling Network in Hepatocellular Carcinoma
    Aliye Aras Perk, Riffat Batool, Sobia Kanwal, Edyta Pawlak-Adamska, Oskar Nowak, Muhammad Sheeraz Ahmad, Qaisar Mansoor, Mirna Azalea Romero, Madeeha Awan, Ammad Ahmad Farooqı et al. · 2017 · Springer eBooks
96. Quantitative Proteomics Reveals Global Reduction of Endocytic Machinery Components in Gliomas
    Dominik P. Buser, Marie‐Françoise Ritz, Suzette Moes, Cristóbal Tostado, Stephan Frank, Martin Spiess, Luigi Mariani, Paul Jenö, Jean‐Louis Boulay, Gregor Hütter · 2019 · SSRN Electronic Journal
97. Propofol Improves Survival In A Murine Model of Sepsis Via Inhibiting Rab5a -Mediated Intracellular Trafficking of TLR4
    Bowei Zhou, Fang-Ling Zhang, Wenjuan Zhang, Xiao Yi Yang, Zhiwen Yao, Zhengzheng Yan, Bing-Cheng Zhao, Jin Zhao, Wei-Jie Feng, Xiao-Dong Chen et al. · 2021 · Research Square
98. C -reactive protein promotes tumor progression in Hepatocellular Carcinom by 1 interacting with Ephrin type B receptor 3
    Yi Yang, Sha She, Min Hee Yang, Shi Ying Li, Huai Dong Hu, Hong Ren · 2021 · Research Square
99. C-Reactive Protein Promotes Tumor Progression in Hepatocellular Carcinom by Interacting with Ephrin Type-B Receptor 3
    Sha She, Min Yang, Shi Ying Li, Huai Dong Hu, Yixuan Yang, Hong Ren · 2021 · Research Square
100. P300-dependent acetylation of histone H3 is required for EGFR-mediated HMGA2 transcription in hepatocellular carcinoma
     Chao Liang, Jie Niu, Xiao Wang, Xin Yao, Ruohan Yang, Zhansheng Zhang, Fan‐Ye Liu, Wenqi Li, Shuhua Pei, Hua Sun et al. · 2020